Key result
Female gender remains linked to torsade de pointes risk independent of postdose QTc.
Why the study?
Is female gender an independent risk factor for torsade de pointes after accounting for postdose QTc prolongation?
Observational (n=22,214)
Is female gender an independent risk factor for torsade de pointes after accounting for postdose QTc prolongation?
Female gender is an independent risk factor for torsade de pointes, even after adjusting for postdose QTc prolongation.
Several risk factors for development of a potentially fatal ventricular arrhythmia, torsade de pointes, have been observed, including female gender. However, in most investigations, only few torsade events were included and/or rarely were postdose heart rate corrected QT (QTc) measurements included, as a surrogate of drug exposure. We developed a multivariate logistic regression model using data from 22,214 patients (33% women) with 84 torsade events (56% women) to evaluate the relationship between risk factors for torsade using data from four anti-arrhythmic drug development programs. Before model development, we evaluated different QT/QTc postdose metrics (average, maximum, etc.) to determine which QT metric should be included into the model. The developed multivariate model showed that, after accounting for known risk factors for torsade and postdose QTc, that female gender remained a significant risk factor for torsade.
No takes yet. Share an insight, caveat, or question.
Johannesen et al. (2017) conducted an observational in Torsade de pointes (n=22,214). Anti-arrhythmic drugs was evaluated on Torsade de pointes. Female gender remained a significant risk factor for torsade de pointes after accounting for known risk factors and postdose QTc in a multivariate model of 22,214 patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: